Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy, Safety and Tolerability of AFQ056 in Fragile X Patients

This study has been completed.
Sponsor:
Information provided by:
Novartis
ClinicalTrials.gov Identifier:
NCT00718341
First received: July 17, 2008
Last updated: May 5, 2010
Last verified: May 2010